Mutations in Fbx4 inhibit dimerization of the SCFFbx4 ligase and contribute to cyclin D1 overexpression in human cancer

被引：123

作者：

Barbash, Olena ^{[1
,2
]}

Zamfirova, Petia ^{[1
]}

Lin, Douglas I. ^{[1
,2
]}

Chen, Xiangmei ^{[5
]}

Yang, Ke ^{[5
]}

Nakagawa, Hiroshi ^{[3
,4
]}

Lu, Fengmin ^{[5
]}

Rustgi, Anil K. ^{[3
,4
]}

Diehl, J. Alan ^{[1
,2
]}

机构：

[1] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA

[2] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA

[3] Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA

[4] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA

[5] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100083, Peoples R China

来源：

CANCER CELL | 2008年 / 14卷 / 01期

关键词：

D O I：

10.1016/j.ccr.2008.05.017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SCFFbx4 was recently identified as the E3 ligase for cyclin D1. We now describe cell-cycle-dependent phosphorylation and dimerization of Fbx4 that is regulated by GSK3 beta and is defective in human cancer. We present data demonstrating that a pathway involving Ras-Akt-GSK3 beta controls the temporal phosphorylation and dimerization of the SCFFbx4 E3 ligase. Inhibition of Fbx4 activity results in accumulation of nuclear cyclin D1 and oncogenic transformation. The importance of this regulatory pathway for normal cell growth is emphasized by the prevalence of mutations in Fbx4 in human cancer that impair dimerization. Collectively, these data reveal that inactivation of the cyclin D1 E3 ligase likely contributes to cyclin D1 overexpression in a significant fraction of human cancer.

引用

页码：68 / 78

页数：11

共 40 条

[1] Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication
Aggarwal, Priya
Lessie, Matthew D.
Lin, Douglas I.
Pontano, Laura
Gladden, Andrew B.
Nuskey, Beth
Goradia, Ami
Wasik, Mariusz A.
Klein-Szanto, Andres J. P.
Rustgi, Anil K.
Bassing, Craig H.
Diehl, J. Alan
[J]. GENES & DEVELOPMENT, 2007, 21 (22) : 2908 - 2922
[2] Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
Alt, JR
Cleveland, JL
Hannink, M
Diehl, JA
[J]. GENES & DEVELOPMENT, 2000, 14 (24) : 3102 - 3114
[3] Large-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil, SA
Jedrychowski, M
Schwartz, D
Elias, JE
Villén, J
Li, JX
Cohn, MA
Cantley, LC
Gygi, SP
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) : 12130 - 12135
[4] Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1
Benzeno, S.
Lu, F.
Guo, M.
Barbash, O.
Zhang, F.
Herman, J. G.
Klein, P. S.
Rustgi, A.
Diehl, J. A.
[J]. ONCOGENE, 2006, 25 (47) : 6291 - 6303
[5] Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells - Evidence for cullin dimerization
Chew, Eng-Hui
Poobalasingam, Thurka
Hawkey, Christopher J.
Hagen, Thilo
[J]. CELLULAR SIGNALLING, 2007, 19 (05) : 1071 - 1080
[6] The F-box: a new motif for ubiquitin dependent proteolysis in cell cycle regulation and signal transduction
Craig, KL
Tyers, M
[J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1999, 72 (03) : 299 - 328
[7] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
CROSS, DAE
ALESSI, DR
COHEN, P
ANDJELKOVICH, M
HEMMINGS, BA
[J]. NATURE, 1995, 378 (6559) : 785 - 789
[8] AMPLIFICATION OF CHROMOSOME BAND 11Q13 AND A ROLE FOR CYCLIN D1 IN HUMAN BREAST-CANCER
DICKSON, C
FANTL, V
GILLETT, C
BROOKES, S
BARTEK, J
SMITH, R
FISHER, C
BARNES, D
PETERS, G
[J]. CANCER LETTERS, 1995, 90 (01) : 43 - 50
[9] Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquintin-proteasome pathway
Diehl, JA
Zindy, F
Sherr, CJ
[J]. GENES & DEVELOPMENT, 1997, 11 (08) : 957 - 972
[10] Cycling to cancer with cyclin D1
Diehl, JA
[J]. CANCER BIOLOGY & THERAPY, 2002, 1 (03) : 226 - 231

← 1 2 3 4 →